U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07616245) titled 'MCT Enteral Feeding to Reduce Chyle Leak After Oesophagectomy' on Feb. 16.
Brief Summary: Chyle leak (chylothorax) is a recognised complication following minimally invasive oesophagectomy for oesophageal cancer and may result in prolonged hospital stay, nutritional compromise, and need for additional interventions.
Medium-chain triglyceride (MCT) feeds reduce lymphatic flow as they are absorbed directly via the portal circulation rather than through the thoracic duct. While MCT feeds are commonly used in the management of established chyle leaks, their role in prevention has not been evaluated in a randomised controlled trial.
This...